This one is an unusual case, as the clinical trial is coming after the first patient (Scolyer) was treated. It's also interesting due to its aspect of "Physician, heal thyself", as Scolyer's own research formed the basis of his treatment. Scolyer doesn't seem to have been directly involved in his treatment, in that it was designed by his collaborator, Georgina Long, and executed by another team.

A scheduled clinical trial is fairly late in the process.

It’s a specific treatment being evaluated not just some pathways discovered in rodents that looks promising.

It's always cancer treatments and battery technology that gets pushed to the top of tech news sites for some reason but it never results in a "this problem is now fixed". Battery tech is incremental at best and nowadays may suffer from its own scale, that is, billions invested into battery factories set up to churn out batteries using a certain technique, which disincentivises new techniques.

But with batteries I like to think there's still plenty of investor money and healthy competition, so a large scale solid state battery plant may yet come to be.

Agreed. Good but very early news isn't that interesting. It needs at minimum a clinical trial.